306 related articles for article (PubMed ID: 25466963)
21. Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: preliminary report based on interobserver agreement.
Zen Y; Aishima S; Ajioka Y; Haratake J; Kage M; Kondo F; Nimura Y; Sakamoto M; Sasaki M; Shimamatsu K; Wakasa K; Park YN; Chen MF; Atomi Y; Nakanuma Y
Pathol Int; 2005 Apr; 55(4):180-8. PubMed ID: 15826244
[TBL] [Abstract][Full Text] [Related]
22. Loss of ARID1A Expression Presents a Novel Pathway of Carcinogenesis in Biliary Carcinomas.
Sasaki M; Nitta T; Sato Y; Nakanuma Y
Am J Clin Pathol; 2016 Jun; 145(6):815-25. PubMed ID: 27334809
[TBL] [Abstract][Full Text] [Related]
23. Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver.
Shimonishi T; Zen Y; Chen TC; Chen MF; Jan YY; Yeh TS; Nimura Y; Nakanuma Y
Hum Pathol; 2002 May; 33(5):503-11. PubMed ID: 12094375
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic Study of Biliary Intraepithelial Neoplasia in Cholangiocarcinoma.
Kim HJ; Kim JS; Kim BH; Bak YT
Dig Surg; 2018; 35(2):116-120. PubMed ID: 28490009
[TBL] [Abstract][Full Text] [Related]
25. Extensive biliary intraepithelial neoplasia (BilIN) and multifocal early intrahepatic cholangiocarcinoma in non-biliary cirrhosis.
Rougemont AL; Genevay M; McKee TA; Gremaud M; Mentha G; Rubbia-Brandt L
Virchows Arch; 2010 Jun; 456(6):711-7. PubMed ID: 20428886
[TBL] [Abstract][Full Text] [Related]
26. Decrease of deleted in malignant brain tumour-1 (DMBT-1) expression is a crucial late event in intrahepatic cholangiocarcinoma.
Sasaki M; Huang SF; Chen MF; Jan YY; Yeh TS; Ishikawa A; Mollenhauer J; Poustka A; Tsuneyama K; Nimura Y; Oda K; Nakanuma Y
Histopathology; 2003 Oct; 43(4):340-6. PubMed ID: 14511252
[TBL] [Abstract][Full Text] [Related]
27. Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.
Nakanuma Y; Sasaki M; Sato Y; Ren X; Ikeda H; Harada K
World J Hepatol; 2009 Oct; 1(1):35-42. PubMed ID: 21160963
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy.
Park JM; Huang S; Wu TT; Foster NR; Sinicrope FA
Cancer Biol Ther; 2013 Feb; 14(2):100-7. PubMed ID: 23192274
[TBL] [Abstract][Full Text] [Related]
29. Autophagy-related proteins Beclin-1 and LC3 predict cetuximab efficacy in advanced colorectal cancer.
Guo GF; Jiang WQ; Zhang B; Cai YC; Xu RH; Chen XX; Wang F; Xia LP
World J Gastroenterol; 2011 Nov; 17(43):4779-86. PubMed ID: 22147978
[TBL] [Abstract][Full Text] [Related]
30. KRAS mutation and immunohistochemical profile in intraductal papillary neoplasm of the intrahepatic bile ducts.
Xian ZH; Qin C; Cong WM
Pathol Res Pract; 2018 Jan; 214(1):105-111. PubMed ID: 29103773
[TBL] [Abstract][Full Text] [Related]
31. Regulators of apoptosis in cholangiocarcinoma.
Jhala NC; Vickers SM; Argani P; McDonald JM
Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
[TBL] [Abstract][Full Text] [Related]
32. Liver-intestine cadherin in intraepithelial neoplasia of intrahepatic cholangiocarcinoma.
Inoue M; Ajioka Y; Wakai T; Takamura M; Korita P; Shirai Y; Hatakeyama K
Hepatogastroenterology; 2011; 58(112):2045-51. PubMed ID: 22024075
[TBL] [Abstract][Full Text] [Related]
33. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct.
Sasaki M; Matsubara T; Nitta T; Sato Y; Nakanuma Y
PLoS One; 2013; 8(12):e81706. PubMed ID: 24312577
[TBL] [Abstract][Full Text] [Related]
34. Heat shock proteins 27 and 70 are potential biliary markers for the detection of cholangiocarcinoma.
Sato Y; Harada K; Sasaki M; Yasaka T; Nakanuma Y
Am J Pathol; 2012 Jan; 180(1):123-30. PubMed ID: 22051775
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic and prognostic value of MRP8/MRP14 in intrahepatic cholangiocarcinoma.
Jin GZ; Dong W; Dong H; Yu H; Chen J; Yu WL; Li AJ; Cong WM; Wu MC
Oncotarget; 2015 Nov; 6(36):39357-64. PubMed ID: 26472105
[TBL] [Abstract][Full Text] [Related]
36. Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer.
Nakagawa H; Hayata Y; Yamada T; Kawamura S; Suzuki N; Koike K
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895797
[TBL] [Abstract][Full Text] [Related]
37. [Intraductal papillary neoplasms of the bile duct (IPNB). Diagnostic criteria, carcinogenesis and differential diagnostics].
Schlitter AM; Klöppel G; Esposito I
Pathologe; 2013 Nov; 34 Suppl 2():235-40. PubMed ID: 24196621
[TBL] [Abstract][Full Text] [Related]
38. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type.
Aishima S; Fujita N; Mano Y; Kubo Y; Tanaka Y; Taketomi A; Shirabe K; Maehara Y; Oda Y
Am J Surg Pathol; 2011 Apr; 35(4):590-8. PubMed ID: 21412073
[TBL] [Abstract][Full Text] [Related]
39. A possible involvement of p62/sequestosome-1 in the process of biliary epithelial autophagy and senescence in primary biliary cirrhosis.
Sasaki M; Miyakoshi M; Sato Y; Nakanuma Y
Liver Int; 2012 Mar; 32(3):487-99. PubMed ID: 22098537
[TBL] [Abstract][Full Text] [Related]
40. An immunohistochemical panel of insulin-like growth factor II mRNA-binding protein 3 (IMP3), enhancer of zeste homolog 2 (EZH2), and p53 is useful for a diagnosis in bile duct biopsy.
Sasaki M; Sato Y
Virchows Arch; 2021 Oct; 479(4):697-703. PubMed ID: 34115196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
